Search

everythinglearnresearchcommunity

for

Search:↓

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

The study suggests pandemic stress might worsen or trigger hair loss problems.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

COVID-19 reinfection may trigger alopecia areata.

The COVID-19 pandemic caused most hair transplant surgeons in India to stop working, and many planned to change their safety measures afterwards.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

COVID-19 can cause skin problems.

Women are more likely to have long-term post-COVID symptoms than men.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Many COVID-19 survivors experience long-lasting symptoms, including hair loss and psychological issues.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

The French COVID-19 lockdown caused delays in diagnosing new melanoma cases, making them more severe.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.